Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Haematologica|March 23, 2023
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experienceGerard Socie, Jacques-Emmanuel Galimard, Emmanuel Raffoux, et al.
Blood Cancer Discovery|January 11, 2023
Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal HematopoiesisRathana Kim, Hugo Bergugnat, Lise Larcher, et al.
JCO Precision Oncology|March 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in <i>FANCM</i>-Associated Fanconi AnemiaFrancesco Pegoraro, Lise Larcher, Rathana Kim, et al.
Blood Cancer Journal|June 24, 2022
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Justine Pasanisi, Romane Joudinaud, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Blood|March 22, 2022
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALLMarie Passet, Rathana Kim, Stéphanie Gachet, et al.
Hemasphere|June 17, 2026
<i>CEBP</i> and <i>ZEB2</i> alterations define three distinct subtypes of B-cell acute lymphoblastic leukemiaRathana Kim, Marie Passet, Hugo Bergugnat, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood Advances|July 2, 2025
Asciminib for relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemiaMathilde Chanut, Aurélie Cabannes-Hamy, Marie Balsat, et al.
Blood|March 27, 2026
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy responseSonja Bendig, Alina M Hartmann, Wiebke Wessels, et al.
Pageof 3